Add this result to my export selection LITHIUM CARBONATE | Drug Source: British National Formulary - BNF (Add filter) 11 February 2021 Indications, dose, contra-indications, side-effects, interactions, cautions, warnings and other safety information for LITHIUM CARBONATE. Type: Prescribing and Technical Information (Add filter)
Add this result to my export selection LITHIUM CARBONATE | Drug Source: British National Formulary for Children - BNFc (Add filter) 11 February 2021 Indications, dose, contra-indications, side-effects, interactions, cautions, warnings and other safety information for LITHIUM CARBONATE. Type: Prescribing and Technical Information (Add filter)
Add this result to my export selection LITHIUM CARBONATE | Medicinal forms Source: British National Formulary - BNF (Add filter) 11 February 2021 LITHIUM CARBONATE Tablet Modified-release tablet Type: Prescribing and Technical Information (Add filter)
Add this result to my export selection Camcolit 400 mg, controlled release Lithium Carbonate - Summary of Product Characteristics (SmPC) - (emc) Source: electronic Medicines Compendium - eMC (Add filter) There are many similar Summary of Product Characteristics from eMC. View all similar results controlled release Lithium Carbonate. 2. Qualitative and quantitative composition Each film-coated tablet contains 400 mg lithium... Type: Prescribing and Technical Information (Add filter)
Add this result to my export selection LITHIUM CARBONATE | Medicinal forms Source: British National Formulary for Children - BNFc (Add filter) 11 February 2021 LITHIUM CARBONATE Tablet Modified-release tablet Type: Prescribing and Technical Information (Add filter)
Add this result to my export selection Lithium Carbonate Essential Pharma 250 mg film-coated tablets - Patient Information Leaflet (PIL) - (emc) (PDF) Source: electronic Medicines Compendium - eMC (Add filter) There are many similar Patient Information Leaflet from eMC PILs. View all similar results Lit250mgTab-PL-UK-3 Package leaflet: Information for the user Lithium Carbonate Essential Pharma 250 mg film-coated tablets Read all of... Type: Information for the Public (Add filter)
Add this result to my export selection Lithium carbonate (Priadel) 200mg and 400mg tablets - Supply Disruption Update Published by Department of Health and Social Care, 04 January 2021 Alert advises there is no longer a need to implement switching of patients from Priadel to an alternative lithium preparation. Patients who have been switched should be given the option of switching... Read Summary Type: Medicines Current Awareness (Add filter)
Add this result to my export selection Hemodialysis for lithium poisoning Source: Cochrane Database of Systematic Reviews (Add filter) 16 September 2015 Background Lithium salts, particularly lithium carbonate, are frequently used to treat bipolar disorder and mania.... Type: Systematic Reviews (Add filter)
Add this result to my export selection Lithium carbonate (Priadel) 200mg and 400mg modified release tablets - Supply Disruption Source: Medicines and Healthcare products Regulatory Agency - MHRA (Add filter) Published by Medicines and Healthcare products Regulatory Agency, 21 August 2020 Priadel® 200mg and 400mg modified-release tablets are being discontinued in the UK and remaining supplies of both strengths are expected to be exhausted by April 2021. This alert contains advice on... Read Summary
Add this result to my export selection Priadel (lithium carbonate) will remain on the market after new price is agreed by the government Published by British Medical Journal, 25 November 2020 After negotiating new prices with the Department of Health and Social Care (DHSC), Essential Pharma has agreed to keep supplying the NHS with Priadel, which it previously announced it would be... Read Summary SPS comment
